Subscribe
The company is completing its transition from recovery play to fully fledged growth stock – and shareholders are reaping the rewards
A January profit warning means these shares are cheaper than they should be
The macro backdrop is overshadowing the company’s transformation, but it may soon get the chance to prove itself
It has cast off legacy divisions and is ‘full steam ahead’ in pursuing higher-margin work
New oil and gas assets in Nigeria promise to send production through the roof – but the risks are high
Chemicals company has a new management team and a new focus on shareholder returns Â
Rentokil is faltering – and this quality US stock is feeling the benefit
Retail used to be a dirty word in property but if you pick the right brands in the right location, your strategy can be on point
Drug development is coming back in vogue and this fund’s ‘full life cycle’ approach means it’s ready to capture the gains
Falling debt and better cash generation are removing the risks of owning this household brand
